Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Haemolytic anaemia
ADR ID BADD_A01933
ADR Hierarchy
01      Blood and lymphatic system disorders
01.06      Haemolyses and related conditions
01.06.03      Anaemias haemolytic NEC
01.06.03.002      Haemolytic anaemia
Description A condition of inadequate circulating red blood cells (ANEMIA) or insufficient HEMOGLOBIN due to premature destruction of red blood cells (ERYTHROCYTES). | Acquired anemia due to destruction of red blood cells by physical trauma such as FIBRIN strands in the blood vessels, artificial heart valve, AORTIC COARCTATION. I can also be associated with hematologic diseases such as DISSEMINATED INTRAVASCULAR COAGULATION; HEMOLYTIC-UREMIC SYNDROME; and THROMBOTIC THROMBOCYTOPENIC PURPURA. [MeSH]
MedDRA Code 10018916
MeSH ID D000743
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Acquired haemolytic anaemia | Acquired haemolytic anaemia, unspecified | Acquired haemolytic anaemias | Acquired hemolytic anemia, unspecified | Acquired hemolytic anemias | Anaemia haemolytic | Anaemia primaquine sensitivity | Anemia hemolytic (NOS) | Anemia hemolytic occult | Anemia primaquine sensitivity type | Haemolytic anaemia | Haemolytic anaemia acquired | Haemolytic anaemia drug-induced | Haemolytic anaemia NOS | Hemolytic anemia | Hemolytic anemia (NOS) | Hemolytic anemia with antidrug antibody | Non-autoimmune haemolytic anaemia | Non-autoimmune haemolytic anaemias | Non-autoimmune hemolytic anemia, unspecified | Non-autoimmune hemolytic anemias | Other non-autoimmune hemolytic anemias | Primaquine sensitivity anaemia | Primaquine sensitivity anemia | Acquired hemolytic anemia | Anemia hemolytic | Hemolytic anemia acquired | Hemolytic anemia drug-induced | Non-autoimmune hemolytic anemia | Anaemia haemolytic occult | Haemolytic anaemia with antidrug antibody | Non-autoimmune haemolytic anaemia, unspecified | Anaemia primaquine sensitivity type | Acute hemolytic anemia | Acute haemolytic anaemia | Anemia, Hemolytic | Hemolytic Anemia | Microangiopathic Hemolytic Anemia | Anemia, Hemolytic, Acquired | Hemolytic Anemia, Acquired | Acquired Hemolytic Anemia | Anemia, Acquired Hemolytic | Anemia, Microangiopathic | Microangiopathic Anemia
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01252Leflunomide0.000643%
BADD_D01253Lenalidomide--
BADD_D01258Leucovorin0.002478%
BADD_D01265Levetiracetam0.000596%
BADD_D01275Levofloxacin0.000211%
BADD_D01300Lisinopril--
BADD_D01309Lomefloxacin--
BADD_D01310Lomefloxacin hydrochloride--
BADD_D01316Loracarbef--
BADD_D01317Loratadine0.000097%
BADD_D01318Lorazepam--
BADD_D01322Losartan--
BADD_D01325Lovastatin--
BADD_D01337Mafenide--
BADD_D01338Mafenide acetate--
BADD_D01352Maraviroc--
BADD_D01359Mechlorethamine--
BADD_D01363Meclofenamate sodium--
BADD_D01366Medroxyprogesterone acetate--
BADD_D01368Mefenamic acid--
BADD_D01376Melphalan--
BADD_D01377Melphalan hydrochloride--
BADD_D01386Mephenytoin--
BADD_D01393Meropenem--
BADD_D01394Merrem i.v.--
BADD_D01395Mersyndol--
BADD_D01400Metaxalone--
BADD_D01401Metformin0.000092%
BADD_D01410Methazolamide--
BADD_D01414Methimazole0.000303%
The 7th Page    First    Pre   7 8 9 10 11    Next   Last    Total 13 Pages
ADReCS-Target
ADR Term Drug Name Target